KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Accumulated Expenses: 2017-2025

Historic Other Accumulated Expenses for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $665.0 million.

  • Elanco Animal Health's Other Accumulated Expenses fell 2.92% to $665.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $665.0 million, marking a year-over-year decrease of 2.92%. This contributed to the annual value of $643.0 million for FY2024, which is 57.21% up from last year.
  • Elanco Animal Health's Other Accumulated Expenses amounted to $665.0 million in Q3 2025, which was up 11.58% from $596.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Other Accumulated Expenses ranged from a high of $685.0 million in Q3 2024 and a low of $377.0 million during Q1 2023.
  • Over the past 3 years, Elanco Animal Health's median Other Accumulated Expenses value was $574.0 million (recorded in 2024), while the average stood at $560.7 million.
  • Over the last 5 years, Elanco Animal Health's Other Accumulated Expenses had its largest YoY gain of 163.33% in 2021, and its largest YoY loss of 26.68% in 2021.
  • Over the past 5 years, Elanco Animal Health's Other Accumulated Expenses (Quarterly) stood at $433.0 million in 2021, then climbed by 4.85% to $454.0 million in 2022, then dropped by 9.91% to $409.0 million in 2023, then spiked by 57.21% to $643.0 million in 2024, then declined by 2.92% to $665.0 million in 2025.
  • Its last three reported values are $665.0 million in Q3 2025, $596.0 million for Q2 2025, and $576.0 million during Q1 2025.